Elevated renal norepinephrine in proANP gene-disrupted mice is associated with increased tyrosine hydroxylase expression in sympathetic ganglia

Regulatory Peptides

Volumn 143, Issue 1-3, 2007, Pages 90-96

  O'Tierney, Perrie F ^a   Tse, M Yat ^a   Pang, Stephen C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Adrenal; Atrial natriuretic peptide; Kidney; Mouse; Norepinephrine; Tyrosine Hydroxylase

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; ENZYME ANALYSIS; GENE; GENE DISRUPTION; HYPERTENSION; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROANP GENE; PROTEIN EXPRESSION; SYMPATHETIC GANGLION; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BLOTTING, WESTERN; BODY WEIGHT; CATECHOLAMINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIA, SYMPATHETIC; GENE EXPRESSION; KIDNEY; MALE; MICE; MICE, KNOCKOUT; MUTATION; NOREPINEPHRINE; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 34547692988     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.03.007     Document Type: Article

References (39)

1. John S.W., Krege J.H., Oliver P.M., Hagaman J.R., Hodgin J.B., Pang S.C., Flynn T.G., and Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267 (1995) 679-681
2. Melo L.G., Veress A.T., Ackermann U., Steinhelper M.E., Pang S.C., Tse Y., and Sonnenberg H. Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone. Cardiovasc Res 43 (1999) 437-444
3. Melo L.G., Veress A.T., Ackermann U., Pang S.C., Flynn T.G., and Sonnenberg H. Chronic hypertension in ANP knockout mice: contribution of peripheral resistance. Regul Pept 79 (1999) 109-115
4. Debinski W., Kuchel O., Buu N.T., Tremblay J., and Hamet P. Atrial natriuretic factor constitutes an intrinsic functional unit within superior cervical ganglia of the rat. Neuroscience 36 (1990) 21-26
5. Flatmark T. Catecholamine biosynthesis and physiological regulation in neuroendocrine cells. Acta Physiol Scand 168 (2000) 1-17
6. Grisk O., Frey B.A., Uber A., and Rettig R. Sympathetic activity in early renal posttransplantation hypertension in rats. Am J Physiol Regul Integr Comp Physiol 279 (2000) R1737-R1744
7. Kuchel O., Debinski W., Racz K., Buu N.T., Garcia R., Cusson J.R., Larochelle P., Cantin M., and Genest J. An emerging relationship between peripheral sympathetic nervous activity and atrial natriuretic factor. Life Sci 40 (1987) 1545-1551
8. Floras J.S. Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans. Am J Physiol 269 (1995) R406-R412
9. Fernandez B.E., Leder M., Fernandez G., Bianciotti L.G., and Vatta M.S. Atrial natriuretic factor modifies the biosynthesis and turnover of norepinephrine in the rat adrenal medulla. Biochem Biophys Res Commun 238 (1997) 343-346
10. Holtz J., Sommer O., and Bassenge E. Inhibition of sympathoadrenal activity by atrial natriuretic factor in dogs. Hypertension 9 (1987) 350-354
11. Atlas S.A., and Maack T. Effects of atrial natriuretic factor on the kidney and the renin-angiotensin-aldosterone system. Endocrinol Metab Clin N Am 16 (1987) 107-143
12. Emori T., Hirata Y., Imai T., Eguchi S., Kanno K., and Marumo F. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 133 (1993) 2474-2480
13. Neuser D., Stasch J.P., Knorr A., and Kazda S. Inhibition by atrial natriuretic peptide of endothelin-1-stimulated proliferation of vascular smooth-muscle cells. J Cardiovasc Pharmacol 22 Suppl 8 (1993) S257-S261
14. Armando I., Jezova M., Bregonzio C., Baiardi G., and Saavedra J.M. Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase. Ann N Y Acad Sci 1018 (2004) 302-309
15. Lange D.L., Haywood J.R., and Hinojosa-Laborde C. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 35 (2000) 385-390
16. Honrath U., Chong C.K., Melo L.G., and Sonnenberg H. Effect of saline infusion on kidney and collecting duct function in atrial natriuretic peptide (ANP) gene "knockout" mice. Can J Physiol Pharm 77 (1999) 454-457
17. Grisk O. Sympatho-renal interactions in the determination of arterial pressure: role in hypertension. Exp Physiol 90 (2005) 183-187
18. Folkow B., Gothberg G., Lundin S., and Ricksten S.E. Structural "resetting" of the renal vascular bed in spontaneously hypertensive rats (SHR). Acta Physiol Scand 100 (1977) 270-272
19. Folkow B., Hallback M., Lundgren Y., and Weiss L. Renal vascular resistance in spontaneously hypertensive rats. Acta Physiol Scand 83 (1971) 96-105
20. Angelis E., Tse M.Y., and Pang S.C. Interactions between atrial natriuretic peptide and the renin-angiotensin system during salt-sensitivity exhibited by the proANP gene-disrupted mouse. Mol Cell Biochem 276 (2005) 121-131
21. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83 (1977) 346-356
22. Sangaralingham S.J., Pak B.J., Tse M.Y., Angelis E., Adams M.A., Smallegange C., and Pang S.C. Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy. Mol Cell Biochem 245 (2003) 183-190
23. Adams M.A., Bobik A., and Korner P.I. Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function. Hypertension 14 (1989) 191-202
24. Grassi G., and Esler M. The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player?. J Hypertens 20 (2002) 1071-1073
25. Ferguson M., Ryan G.B., and Bell C. The innervation of the renal cortex in the dog. An ultrastructural study. Cell Tissue Res 253 (1988) 539-546
26. Moss N.G. Renal function and renal afferent and efferent nerve activity. Am J Physiol 243 (1982) F425-F433
27. Winternitz S.R., Katholi R.E., and Oparil S. Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest 66 (1980) 971-978
28. Katholi R.E., Naftilan A.J., and Oparil S. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension 2 (1980) 266-273
29. Katholi R.E., Naftilan A.J., Bishop S.P., and Oparil S. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion. Hypertension 5 (1983) 427-435
30. Lee R.M., Triggle C.R., Cheung D.W., and Coughlin M.D. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension 10 (1987) 328-338
31. Moritz K.M., and Wintour E.M. Functional development of the meso- and metanephros. Pediatr Nephrol 13 (1999) 171-178
32. Tsuda K., Kuchii M., Shima H., Nishio I., and Masuyama Y. Effects of alpha-human atrial natriuretic peptides on neurosecretion and vascular responsiveness in spontaneously hypertensive rats. J Hypertens Suppl 4 (1986) S331-S333
33. Pettersson A., Hedner J., and Hedner T. Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure. Acta Physiol Scand 135 (1989) 487-492
34. Arita D.Y., Di Marco G.S., Schor N., and Casarini D.E. Purification and characterization of the active form of tyrosine hydroxylase from mesangial cells in culture. J Cell Biochem 87 (2002) 58-64
35. Jahed A., and Kawaja M.D. The influences of p75 neurotrophin receptor and brain-derived neurotrophic factor in the sympathetic innervation of target tissues during murine postnatal development. Auton Neurosci 118 (2005) 32-42
36. Yanagihara N., Okazaki M., Terao T., Uezono Y., Wada A., and Izumi F. Stimulatory effects of brain natriuretic peptide on cyclic GMP accumulation and tyrosine hydroxylase activity in cultured bovine adrenal medullary cells. Naunyn-Schmiedeberg's Arch Pharmacol 343 (1991) 89-295
37. Vatta M.S., Presas M., Bianciotti L.G., Zarrabeitia V., and Fernandez B.E. B and C types natriuretic peptides modulate norepinephrine uptake and release in the rat hypothalamus. Regul Pept 65 (1996) 75-184
38. Tse M.Y., Watson J.D., Sarda I.R., Flynn T.G., and Pang S.C. Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem 219 (2001) 9-105
39. Houben A.J., van der Z.K., and de Leeuw P.W. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol 19 (2005) 11-419